Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual Report

Nectar Lifesciences Annual Report

Nectar Lifesciences Ltd. has released its Annual Report for FY 2025-26. The 31st Annual General Meeting is scheduled for September 18, 2026, via video conferencing.

Source

BSE filing, NSE: NECLIFE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Nectar Lifesciences Ltd: key numbers

Share price
₹10.33
Market cap
₹231.7 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-292.9 Cr
P/E (TTM)
-0.9×Sector 46.5×
Promoter holding
51.84%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Nectar Lifesciences Ltd

All →

Other annual report announcements

All →